Tissue Kallikrein-1 Suppresses Type I Interferon Responses and Reduces Depressive-Like Behavior in the MRL/lpr Lupus-Prone Mouse Model
International Journal of Molecular Sciences · 19.09.2024 · 25 (18) · 10080
DOI: 10.3390/ijms251810080 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.09.2024. Verfasst von Priyanka S Bhoj und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA. Hauptthemen laut MEDLINE: Depression, Interferon Type I, Lupus Erythematosus, Systemic, Tissue Kallikreins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIAID NIH HHS, NIH-NIAID.
Abstract (Originalsprache)
Excessive production and response to Type I interferons (IFNs) is a hallmark of systemic lupus erythematosus (SLE). Neuropsychiatric lupus (NPSLE) is a common manifestation of human SLE, with major depression as the most common presentation. Clinical studies have demonstrated that IFNα can cause depressive symptoms. We have shown that the kallikrein–kinin system (KKS) [comprised of kallikreins (Klks) and bradykinins] and angiotensin-converting enzyme inhibitors suppressed Type I IFN responses in dendritic cells from lupus-prone mice and human peripheral blood mononuclear cells. Tissue Klk genes are decreased in patients with lupus, and giving exogenous Klk1 ameliorated kidney pathology in mice. We retro-orbitally administered mouse klk1 gene-carrying adenovirus in the Murphy Roths Large lymphoproliferative (MRL/lpr) lupus-prone mice at early disease onset and analyzed immune responses and depressive-like behavior. Klk1 improved depressive-like behavior, suppressed interferon-responsive genes and neuroinflammation, and reduced plasma IFNα levels and proinflammatory cytokines. Klk1 also reduced IFNAR1 and JAK1 protein expression, important upstream molecules in Type I IFN signaling. Klk1 reduced bradykinin B1 receptor expression, which is known to induce proinflammatory response. Together, these findings suggest that Klk1 may be a potential therapeutic candidate to control IFNα production/responses and other inflammatory responses in SLE and NPSLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
- Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
ORCID-Profile: Namdev S Togre, Alecia Seliga
Förderung
- NIDA NIH HHS
- NIAID NIH HHS
- NIH-NIAID
- NIH HHS
- NIH-NIDA
- the Department of Pathology and Laboratory Medicine
Zitieren
APA
Bhoj, P. S., Nocito, C., Togre, N. S., Winfield, M., Lubinsky, C., Khan, S., Mogadala, N., Seliga, A., Unterwald, E. M., Persidsky, Y., & Sriram, U. (2024). Tissue Kallikrein-1 Suppresses Type I Interferon Responses and Reduces Depressive-Like Behavior in the MRL/lpr Lupus-Prone Mouse Model. International Journal of Molecular Sciences, 25(18), 10080. https://doi.org/10.3390/ijms251810080
Vancouver
Bhoj PS, Nocito C, Togre NS, Winfield M, Lubinsky C, Khan S, et al. Tissue Kallikrein-1 Suppresses Type I Interferon Responses and Reduces Depressive-Like Behavior in the MRL/lpr Lupus-Prone Mouse Model. International Journal of Molecular Sciences. 2024;25(18):10080. doi:10.3390/ijms251810080
BibTeX
@article{Bhoj2024,
author = {Bhoj, Priyanka S and Nocito, Cassandra and Togre, Namdev S and Winfield, Malika and Lubinsky, Cody and Khan, Sabeeya and Mogadala, Nikhita and Seliga, Alecia and Unterwald, Ellen M and Persidsky, Yuri and Sriram, Uma},
title = {Tissue Kallikrein-1 Suppresses Type I Interferon Responses and Reduces Depressive-Like Behavior in the MRL/lpr Lupus-Prone Mouse Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {18},
pages = {10080},
doi = {10.3390/ijms251810080}
}
EUVIMED